JP2004256553A5 - - Google Patents

Download PDF

Info

Publication number
JP2004256553A5
JP2004256553A5 JP2004147081A JP2004147081A JP2004256553A5 JP 2004256553 A5 JP2004256553 A5 JP 2004256553A5 JP 2004147081 A JP2004147081 A JP 2004147081A JP 2004147081 A JP2004147081 A JP 2004147081A JP 2004256553 A5 JP2004256553 A5 JP 2004256553A5
Authority
JP
Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2004147081A
Other languages
Japanese (ja)
Other versions
JP4188279B2 (ja
JP2004256553A (ja
Filing date
Publication date
Priority claimed from US08/316,424 external-priority patent/US6022848A/en
Priority claimed from US08/535,882 external-priority patent/US5939391A/en
Application filed filed Critical
Publication of JP2004256553A publication Critical patent/JP2004256553A/ja
Publication of JP2004256553A5 publication Critical patent/JP2004256553A5/ja
Application granted granted Critical
Publication of JP4188279B2 publication Critical patent/JP4188279B2/ja
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

JP2004147081A 1994-09-30 2004-05-17 幹細胞増殖インヒビターおよびその使用 Expired - Fee Related JP4188279B2 (ja)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US08/316,424 US6022848A (en) 1993-03-31 1994-09-30 Inhibitor of stem cell proliferation and uses thereof
US08/535,882 US5939391A (en) 1993-03-31 1995-09-28 Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation

Related Parent Applications (1)

Application Number Title Priority Date Filing Date
JP51195796A Division JP3953511B2 (ja) 1994-09-30 1995-09-29 幹細胞増殖インヒビターおよびその使用

Related Child Applications (1)

Application Number Title Priority Date Filing Date
JP2007317741A Division JP2008088186A (ja) 1994-09-30 2007-12-07 幹細胞増殖インヒビターおよびその使用

Publications (3)

Publication Number Publication Date
JP2004256553A JP2004256553A (ja) 2004-09-16
JP2004256553A5 true JP2004256553A5 (enExample) 2005-09-22
JP4188279B2 JP4188279B2 (ja) 2008-11-26

Family

ID=26980434

Family Applications (3)

Application Number Title Priority Date Filing Date
JP51195796A Expired - Fee Related JP3953511B2 (ja) 1994-09-30 1995-09-29 幹細胞増殖インヒビターおよびその使用
JP2004147081A Expired - Fee Related JP4188279B2 (ja) 1994-09-30 2004-05-17 幹細胞増殖インヒビターおよびその使用
JP2007317741A Withdrawn JP2008088186A (ja) 1994-09-30 2007-12-07 幹細胞増殖インヒビターおよびその使用

Family Applications Before (1)

Application Number Title Priority Date Filing Date
JP51195796A Expired - Fee Related JP3953511B2 (ja) 1994-09-30 1995-09-29 幹細胞増殖インヒビターおよびその使用

Family Applications After (1)

Application Number Title Priority Date Filing Date
JP2007317741A Withdrawn JP2008088186A (ja) 1994-09-30 2007-12-07 幹細胞増殖インヒビターおよびその使用

Country Status (17)

Country Link
US (2) US5939391A (enExample)
EP (1) EP0784677B1 (enExample)
JP (3) JP3953511B2 (enExample)
CN (2) CN1328285C (enExample)
AT (1) ATE263236T1 (enExample)
CA (1) CA2201105C (enExample)
DE (1) DE69532813T2 (enExample)
DK (1) DK0784677T3 (enExample)
ES (1) ES2216019T3 (enExample)
FI (1) FI117468B (enExample)
IL (1) IL115473A (enExample)
MX (1) MX9702266A (enExample)
NO (1) NO319575B1 (enExample)
NZ (2) NZ335108A (enExample)
PT (1) PT784677E (enExample)
RU (1) RU2186579C2 (enExample)
WO (1) WO1996010634A1 (enExample)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2185649T3 (es) 1993-03-31 2003-05-01 Wellstat Therapeutics Corp Inhibidores de la proliferacion de las celulas germinales y sus utilizaciones.
US6610654B2 (en) * 1993-03-31 2003-08-26 Wellstat Therapeutics Corporation Inhibitor of stem cell proliferation and uses thereof
US5939391A (en) * 1993-03-31 1999-08-17 Pro-Neuron, Inc. Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
EP1362596A3 (en) * 1994-09-30 2004-03-10 Wellstat Therapeutics Corporation Inhibitor of stem cell proliferation and uses thereof
US5861483A (en) 1996-04-03 1999-01-19 Pro-Neuron, Inc. Inhibitor of stem cell proliferation and uses thereof
GB9700154D0 (en) 1997-01-07 1997-02-26 Primapharma Ltd Peptides
JP2000095794A (ja) * 1998-09-22 2000-04-04 Itoham Foods Inc エンケファリン分解酵素の阻害剤
US6488828B1 (en) * 2000-07-20 2002-12-03 Roche Diagnostics Corporation Recloseable biosensor
WO2005026380A2 (en) * 2003-09-10 2005-03-24 Southern Research Institute Bone marrow proliferation assay
EP1909815A4 (en) 2005-07-26 2011-05-18 Cms Peptides Patent Holding Company Ltd NEW BIOLOGICALLY ACTIVE PEPTIDES AND THEIR NEW USES
RU2317074C1 (ru) * 2006-03-16 2008-02-20 Общество с ограниченной ответственностью "МБФ" Ингибитор дифференцировки кроветворных клеток-предшественников
RU2320364C1 (ru) * 2006-08-21 2008-03-27 Закрытое Акционерное Общество "Центр "Пептос" Способ лечения злокачественных новообразований
RU2328304C1 (ru) * 2007-03-22 2008-07-10 Общество с ограниченной ответственностью "Геленпол" Агент защиты клеток крови и восстановления кроветворной системы и фармакологическая комбинация для лечения онкологических больных
WO2008136699A1 (fr) * 2007-05-04 2008-11-13 Igor Alexandrovich Bazikov Patch transdermique à microcapsules et procédé de fabrication correspondant
WO2013078286A1 (en) * 2011-11-22 2013-05-30 Cornell University Methods for stimulating hematopoietic recovery by inhibiting tgf beta signaling
US9220706B2 (en) 2012-06-01 2015-12-29 National Institutes Of Health (Nih) Inhibition of leukemic stem cells by PP2A activating agents
WO2014078787A1 (en) * 2012-11-19 2014-05-22 Wellstat Therapeutics Corporation Stem cell mobilization and tissue repair and regeneration
RU2535972C2 (ru) * 2012-12-24 2014-12-20 Андрей Степанович БРЮХОВЕЦКИЙ Противоопухолевый индивидуальный протеом-основанный таргетный клеточный препарат, способ его получения и применение этого препарата для терапии рака и других злокачественных новообразований
RU2537141C1 (ru) * 2013-11-20 2014-12-27 государственное бюджетное образовательное учреждение высшего профессионального образования "Первый Санкт-Петербургский государственный медицинский университет имени академика И.П. Павлова" Министерства здравоохранения Российской Федерации Способ определения способности клеток костного мозга к делению
CN104817613A (zh) * 2014-01-30 2015-08-05 陈光健 寡肽cd06及其制备方法和应用
CN104817622A (zh) * 2014-01-30 2015-08-05 陈光健 寡肽cd04及其制备方法和应用
CN104817615A (zh) * 2014-01-30 2015-08-05 陈光健 寡肽cd05及其制备方法和应用
CN104817625A (zh) * 2014-01-30 2015-08-05 陈光健 寡肽cd03及其制备方法和应用
CN105294830A (zh) * 2014-06-18 2016-02-03 陈光健 一种二肽分子及其制备方法和应用
US10953107B2 (en) * 2018-06-15 2021-03-23 Trustees Of Boston University Polypeptide compositions and methods for site-specific targeting of therapeutic agents

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA1142466A (en) * 1979-01-09 1983-03-08 Cesar Milstein Cell lines
US4683194A (en) * 1984-05-29 1987-07-28 Cetus Corporation Method for detection of polymorphic restriction sites and nucleic acid sequences
US5449759A (en) * 1987-05-16 1995-09-12 Somatogen, Inc. Hemoglobins with intersubunit desulfide bonds
GB8711614D0 (en) * 1987-05-16 1987-06-24 Medical Res Council Proteins
US5545727A (en) * 1989-05-10 1996-08-13 Somatogen, Inc. DNA encoding fused di-alpha globins and production of pseudotetrameric hemoglobin
IL94361A (en) * 1989-05-10 1995-07-31 Somatogenetics Int Polypeptides, revombinant dna molecules and method of producing a human hemoglobin-like protein
DK0494268T4 (da) * 1989-09-25 1999-11-08 Genetics Inst Fremgangsmåde til inhibering af stamcellers vækst
US5239061A (en) * 1990-06-20 1993-08-24 Research Corporation Technologies, Inc. Modified human hemoglobin, blood substitutes containing the same, and vectors for expressing the modified hemoglobin
DE69132763D1 (de) * 1990-12-20 2001-11-15 Univ Alabama Res Foundation Bi Transgenes, vernetztes hämoglobin
AU2140492A (en) * 1991-05-14 1992-12-30 Biopure Corporation Use of hemoglobin in a method for the treatment of tumors with chemotherapeutic agents
US5334706A (en) * 1992-01-30 1994-08-02 Baxter International Administration of low dose hemoglobin to increase perfusion
US5786334A (en) * 1992-08-14 1998-07-28 Technology Resources International, Inc. Hexapeptide having immunostimulatory activity
DE4228458A1 (de) * 1992-08-27 1994-06-01 Beiersdorf Ag Multicistronische Expressionseinheiten und deren Verwendung
US5939391A (en) * 1993-03-31 1999-08-17 Pro-Neuron, Inc. Hemoglobin alpha chain peptide fragments useful for inhibiting stem cell proliferation
US5861483A (en) * 1996-04-03 1999-01-19 Pro-Neuron, Inc. Inhibitor of stem cell proliferation and uses thereof

Similar Documents

Publication Publication Date Title
BE2024C508I2 (enExample)
BE2023C542I2 (enExample)
BE2022C549I2 (enExample)
BE2021C001I2 (enExample)
BE2020C513I2 (enExample)
BE2020C517I2 (enExample)
BE2019C540I2 (enExample)
BE2019C523I2 (enExample)
BE2019C548I2 (enExample)
BE2019C506I2 (enExample)
BE2020C525I2 (enExample)
BE2015C041I2 (enExample)
BE2015C038I2 (enExample)
BE2015C014I2 (enExample)
BE2014C071I2 (enExample)
BE2015C015I2 (enExample)
BE2014C064I2 (enExample)
BE2014C063I2 (enExample)
BE2014C010I2 (enExample)
BE2014C014I2 (enExample)
BE2013C071I2 (enExample)
BE2013C021I2 (enExample)
BE2012C025I2 (enExample)
JP2005156566A5 (enExample)
BE2015C033I2 (enExample)